Axcend and MassTech, Inc. announced that Axcend will offer the MassTech MTE30 as part of a combined liquid ...

In this interview, Professor Stephen Pennington, full professor of proteomics at University College Dublin, explores how mass ...

Explore how clinical multi-omics integration drives systems medicine, detailing data fusion methodologies and lab ...

Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...

The above video shows the top local headlines for the morning of March 9, 2026. LUBBOCK, Texas — Yehia Mechref, a ...

Bioimaging Core Facility The Bioimaging Core Facility is specialized in light microscopy. ChemBioMS - Mass Spectrometry Core Facility The ChemBiosMS - Mass Spectrometry Core Facility is a platform ...

Scientists develop a blood test that detects Alzheimer’s by measuring protein structural changes rather than protein quantity.

The surplus consists largely of degenerate features—multiple peaks spawned by one metabolite through adducts, in-source ...

The Proteomics Core Facility provides comprehensive infrastructure for protein identification, characterization, and quantitation using mass spectrometry-based approaches. Our mission is to support ...

Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...

Exum Instruments Inc. today announced the launch of next generation Massbox®, a significant advancement of its proprietary Laser Ablation Laser Ionization Time of Flight Mass Spectrometry (LALI-TOF-MS ...